Showing results (1-10 of 50) with videos related to
Sort By:
Pageof 5
Advances in Experimental Medicine and Biology|July 9, 2014
Signalling of ApoptinJessica Bullenkamp, Mahvash TavassoliApoptosis : an International Journal on Programmed Cell Death|April 2, 2015
Apoptin interacts with and regulates the activity of protein kinase C beta in cancer cellsJessica Bullenkamp, Joop Gäken, Frederic Festy, et al.International Journal of Cancer|December 20, 2014
MicroRNA-196a promotes an oncogenic effect in head and neck cancer cells by suppressing annexin A1 and enhancing radioresistanceYae-Eun Suh, Nina Raulf, Joop Gäken, et al.Cell Death Discovery|September 1, 2020
Inside the hypoxic tumour: reprogramming of the DDR and radioresistanceKatheryn Begg, Mahvash TavassoliTranslational Oncology|January 19, 2021
Hypoxia-induced therapy resistance: Available hypoxia-targeting strategies and current advances in head and neck cancerVictoria L Codony, Mahvash TavassoliOral Oncology|October 4, 2020
Portrait of a CAF: The story of cancer-associated fibroblasts in head and neck cancerMarcos Custódio, Adrian Biddle, Mahvash TavassoliExperimental Biology and Medicine (Maywood, N.J.)|April 28, 2011
Naturally occurring, tumor-specific, therapeutic proteinsKonstantinos Argiris, Chrysoula Panethymitaki, Mahvash TavassoliCancers|December 11, 2019
Cancer Treatment Goes Viral: Using Viral Proteins to Induce Tumour-Specific Cell DeathJasmine Wyatt, Manuel M Müller, Mahvash TavassoliCell Death Discovery|June 26, 2024
Crosstalk between CAFs and tumour cells in head and neck cancerXinyang Li, Celia González-Maroto, Mahvash TavassoliElife|June 24, 2016
Registered report: Systematic identification of genomic markers of drug sensitivity in cancer cellsJohn P Vanden Heuvel, Jessica Bullenkamp, Pageof 5